United States Molecular Diagnostics Market is expected to reach 4 Billion by 2018

ROSWELL, Ga. - July 14, 2015 - PRLog -- Key facts Covered

• The molecular diagnostic market in US was around US$ 4,000 Million in 2013

• United States Molecular diagnostics test volumes is expected to cross more than 200 Million by 2018

• Myriad genetics holds the second position in the United States molecular diagnostics market

• The oncology test volume in the United States is likely to leapfrog to around 50 Million tests in 2018

• United States genetic testing market was worth more than US$ 1.5 Billion by the year 2018

• The Food pathogen test volume share accounted for around 40% of the total molecular diagnostics application test volume in 2013.

Table of Content

1. Executive Summary

2. United States Molecular Diagnostics Market, Test Volume & Forecast (2010 – 2018)

2.1 United States Molecular Diagnostics Market & Forecast

2.2 United States Molecular Diagnostics Test Volume & Forecast

3. United States Molecular Diagnostics Market & Volume Share (2010 – 2018)

3.1 United States Molecular Diagnostics Market Share & Forecast – Application Wise

3.2 United States Molecular Diagnostics Market Share & Forecast – Company Wise

3.3 United States Molecular Diagnostics Test Volume Share & Forecast – Application Wise

4. United States Molecular Diagnostics Market & Forecast – Application Wise

4.1 Oncology Testing Market (2004 – 2018)

4.1.1 Breast Cancer Testing Market (2004 – 2018)

4.1.2 Colorectal Cancer Testing Market (2004 – 2018)

4.1.3 Prostate Cancer Testing Market (2004 – 2018)

4.1.4 Other Cancer Testing Market (2004 – 2018)

4.2 Infectious Disease Testing Market (2010 – 2018)

4.2.1 Virology Testing Market (2007 – 2018)

4.2.2 HPV Testing Market (2004 – 2018)

4.2.3 HAI Testing Market (2010 – 2018)

4.2.4 Critical Care Testing Market (2010 – 2018)

4.3 Genetic Testing Market (2010 – 2018)

4.4 Blood Screening Market (2006 – 2018)

4.5 Food Pathogen Testing Market (2010 – 2018)

4.6 Tissue Typing (HLA) Testing Market (2008 – 2018)

5. United States Molecular Diagnostics Test Volume – Application Wise

5.1 Oncology Test Volume (2004 – 2018)

5.1.1 Breast Cancer Test Volume (2004 – 2018)

5.1.2 Colorectal Cancer Test Volume (2004 – 2018)

5.1.3 Prostate Cancer Test Volume (2004 – 2018)

5.1.4 Other Cancer Test Volume (2004 – 2018)

5.2 Infectious Disease Test Volume (2010 – 2018)

5.2.1 Virology Test Volume (2007 – 2018)

5.2.2 HPV Test Volume (2004 – 2018)

5.2.3 HAI Test Volume (2010 – 2018)

5.2.4 Critical Care Test Volume (2010 – 2018)

5.3 Genetic Testing Test Volume & Forecast (2010 – 2018)

5.4 Blood Screening Test Volume & Forecast (2006 – 2018)

5.5 Food Pathogen Test Volume & Forecast (2010 – 2018)

5.6 HLA Test Volume & Forecast (2008 – 2018)

6. United States Molecular Diagnostics Market –   Company Wise

6.1 Roche – United States Molecular Diagnostic Sales and Forecast

6.2 Abbott Laboratories – United States Molecular Diagnostic Sales and Forecast

6.3 Myriad Genetics – United States Molecular Diagnostic Sales and Forecast

6.4 Biomerieux – United States Molecular Diagnostic Sales and Forecast

6.5 Qiagen – United States Molecular Diagnostic Sales and Forecast

6.6 Hologic Inc. (Acquired Gen–Probe) – United States Molecular Diagnostic Sales and Forecast

6.7 Becton Dickinson – United States Molecular Diagnostic Sales and Forecast

6.8 Siemens – United States Molecular Diagnostic Sales and Forecast

6.9 Cepheid – United States Molecular Diagnostic Sales and Forecast

6.10 Others – United States Molecular Diagnostic Sales and Forecast

7. United States Molecular Diagnostics Market – Driving Factors

7.1 Point A

7.2 Point B

7.3 Point C

8. United States Molecular Diagnostics Market – Challenges

8.1 Point A

8.2 Point B

8.3 Point C

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Click here to view the report Details: http://www.renub.com/report/united-states-usa-molecular-d...

For more information visit: http://www.renub.com/

Contact Us

Rajat Gupta

Sr. Manager

Sales & Marketing Div

Renub Research

Email: rajat.gupta@renub.com

Phone:  +1-678-302-0700 (USA), +91-120-421-9822, +91-120-254-5750 (India)

Web: http://www.renub.com